Virax Biolabs to Participate at ESCMID Global 2024 Virax Biolabs to Participate at ESCMID Global 2024 PR Newswire LONDON, April 16, 2024 LONDON, April 16, 2024 /PRNewswire/ -- Virax Biolabs Group...
Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price...
Virax Biolabs Group Limited (NASDAQ:VRAX Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 30,100 shares, a...
Virax Biolabs Group Limited (NASDAQ:VRAX Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest...